Prostaglandin Analogues In Eyelash Cosmetics: Rodan & Fields To Settle Litigation For $38M

31 Mar 2022

R&F will establish funds totaling $38m to put the kibosh on claims of fraud and unfair competition in US federal and state class actions, while maintaining it never intended its prostaglandin analogue-containing Lash Boost to impart drug-like structure and/or function effects on the human body. The settlement does not require R&F to stop selling Lash Boost or reformulate the product.

San Francisco-based Rodan & Fields, LLC will shell out $38m to settle multiple class actions in US and California state courts concerning the multi-level marketing firm’s Lash Boost conditioning serum and the prostaglandin analogue that powers it.

According to court documents and the settlement website, California Superior Court Judge Ethan Schulman preliminarily approved plaintiffs’ unopposed settlement...